Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
CEVA, Inc. (CEVA)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
$24.56-12.35%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.80 → 0.80 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CEVA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross margin stays near 88% | Gross margins remain very high near 88%. | Intact | Gross margin falls below 80% in FY25 | Gross margin: 87.44% FY2026-Q2; GAAP. Published target: >= 86%. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202687.441876 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CEVA is a high-risk growth business whose recent results remain weak overall, despite signs of better execution. The long-term thesis is in a watch state, with medium confidence and no fresh break in the thesis.
The valuation model sees CEVA as cheap versus peers, with an expectations gap of 0.83 and medium confidence. That low relative valuation sits alongside weak recent performance, but the evidence does not show that the market already assumes a specific recovery.
Near-term, results could remain uneven: the recent performance trails the industry cohort, and a guidance cut would be a meaningful setback. In 2026-Q2, licensing revenue grew 21% year over year, total revenue rose 13%, gross margins stayed high, and operating profitability improved, supporting management’s stated priorities.
The multi-year view hinges on continued licensing growth, sustained high gross margins, and further progress toward profitability. Near-term conditions also depend on guidance and whether broader technology-sector pressure eases; the evidence flags rate cuts and stabilization among major sector companies as possible tailwinds.
CEVA has encouraging signs in licensing growth and profitability, but its weak relative performance and high risk leave the 1-3 year thesis conditional on continued execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It aims for positive operating income, improving from -$4.5M to -$0.4M in 2025-Q4. |
| Intact |
| Operating income remains below -$4 million beyond 2025-Q4 |
Operating income: $-2.076M FY2026-Q2; GAAP. Published target: >= -$0.4 million. The stored target says 2025-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 10, 2026-2,076,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $31 million | A primary condition in CEVA, Inc.'s published investment case. The stated target is >= $31 million. | Improving | Revenue falls below $27 million in FY25 | Revenue: $29.033M FY2026-Q2; GAAP. Published target: >= $31 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202629,033,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.82 → $0.80 · observed estimates
$0.14B → $0.14B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-07-25 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-07-26 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-07-27 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-07-28 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-07-29 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-07-30 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-07-31 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-01 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-02 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-08-03 | $0.82 | $139,644,760 | 9 / 9 |
| 2026-08-04 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-05 | $0.83 | $140,099,680 | 9 / 9 |
| 2026-08-06 | $0.83 | $140,099,680 | 9 / 9 |
| 2026-08-07 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-08 | $0.83 | $140,099,680 | 9 / 9 |
| 2026-08-09 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-10 | $0.83 | $140,099,680 | 9 / 9 |
| 2026-08-11 | $0.83 | $140,099,680 | 9 / 9 |
| 2026-08-12 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-13 | $0.80 | $141,235,960 | 9 / 9 |
| 2026-08-14 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-15 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-16 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-17 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-18 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-19 | $0.82 | $139,640,751 | 6 / 7 |
| 2026-08-20 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-21 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-22 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-23 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-24 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-25 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-26 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-27 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-28 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-29 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-30 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-08-31 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-01 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-02 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-03 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-04 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-05 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-06 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-07 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-08 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-09 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-10 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-11 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-12 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-13 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-14 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-15 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-16 | $0.80 | $141,214,075 | 7 / 7 |
| 2026-09-17 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-18 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-19 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-20 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-21 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-22 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-23 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-24 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-25 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-26 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-27 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-28 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-29 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-09-30 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-01 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-02 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-03 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-04 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-05 | $0.80 | $141,551,630 | 7 / 7 |
| 2026-10-06 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-07 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-08 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-09 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-10 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-11 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-12 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-13 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-14 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-15 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-16 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-17 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-18 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-19 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-20 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-21 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-22 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-23 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-24 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-25 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-26 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-27 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-28 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-29 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-30 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-10-31 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-11-01 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-11-02 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-11-03 | $0.80 | $141,596,467 | 7 / 7 |
| 2026-11-04 | $0.80 | $141,596,467 | 7 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 8 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.